Structural basis of a human antibody targeting SARS-CoV-2 nucleocapsid protein dimerization domain and interfering with RNA-binding
Abstract The transition of SARS-CoV-2 into a recurrent, seasonal pathogen has underscored the need for the induction of durable immune protection. The nucleocapsid (N) protein is regarded as a promising complementary target for therapeutic and vaccine strategies, owing to its structural robustness,...
Saved in:
| Main Authors: | Shaojie Xue, Suhua He, Zhaoxia Huang, Mei Yang, Guowei Hu, Xiaoxue Chen, Qiuyue Chen, Wenying Zhou, Sixiao Lin, Shoudeng Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-025-08648-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis
by: Onyeka S. Chukwudozie, et al.
Published: (2020-01-01) -
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
by: Leslie R. Zwerwer, et al.
Published: (2025-05-01) -
Thermodynamic Coupling between Folding Correctors and the First of Dimerized Nucleotide Binding Domains in CFTR
by: Guangyu Wang
Published: (2025-07-01) -
The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients
by: Akemi Hara, et al.
Published: (2025-07-01) -
Enhancement of SARS-CoV-2 Receptor Binding Domain -CR3022 Human Antibody Binding Affinity via In silico Engineering Approach
by: Fatemeh Sefid, et al.
Published: (2021-09-01)